COVID-19 neutralizing antibodies predict disease severity and survival

Wilfredo F. Garcia-Beltran, Evan C. Lam, Michael G. Astudillo, Diane Yang, Tyler E. Miller, Jared Feldman, Blake M. Hauser, Timothy M. Caradonna, Kiera L. Clayton, Adam D. Nitido, Mandakolathur R. Murali, Galit Alter, Richelle C. Charles, Anand Dighe, John A. Branda, Jochen K. Lennerz, Daniel Lingwood, Aaron G. Schmidt, A. John Iafrate, Alejandro B. Balazs
doi: https://doi.org/10.1101/2020.10.15.20213512

Data Availability

This study assessed the diagnostic and prognostic performance of SARS-CoV-2 serological and immunological tests and was not a clinical trial. De-identified raw data of the results of serological assays can be provided upon request.

Back to top
Posted October 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email
COVID-19 neutralizing antibodies predict disease severity and survival
Wilfredo F. Garcia-Beltran, Evan C. Lam, Michael G. Astudillo, Diane Yang, Tyler E. Miller, Jared Feldman, Blake M. Hauser, Timothy M. Caradonna, Kiera L. Clayton, Adam D. Nitido, Mandakolathur R. Murali, Galit Alter, Richelle C. Charles, Anand Dighe, John A. Branda, Jochen K. Lennerz, Daniel Lingwood, Aaron G. Schmidt, A. John Iafrate, Alejandro B. Balazs
medRxiv 2020.10.15.20213512; doi: https://doi.org/10.1101/2020.10.15.20213512
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area